Design, Synthesis, In Vitro, and In Silico Enzymatic Evaluations of New Chrysin Sulfonohydrazide Derivatives as Potent α‑Glucosidase Inhibitors
Abstract
Eleven new chrysin sulfonohydrazide derivatives were designed, synthesized, and screened for their in vitro α-glucosidase inhibitory activity. Their structures were unambiguously confirmed using NMR and mass spectrometry. All the synthesized compounds demonstrated significant inhibitory activity against the yeast α-glucosidase with IC50 values ranging from 3.8 ± 0.4 to 9.6 ± 0.6 μM. Among them, compound 8 showed the strongest inhibitory activity, with an IC50 value of 3.8 ± 0.4 μM, which was substantially more potent than the positive control, acarbose (IC50 = 836.1 ± 47.2 μM). Enzyme kinetic studies revealed that compound 8 acts as a competitive inhibitor with a Ki value of 12.9 μM. To further investigate its binding mode, molecular docking and molecular dynamics simulations were performed. The docking results indicated that the enhanced α-glucosidase inhibitory activity was mainly attributed to π-π stacking interactions with Phe137 and hydrogen-bonding interactions involving Ser308, Pro309, Arg312, and Glu350. Molecular dynamics simulations further demonstrated that compound 8 forms stable interactions with key amino acid residues through hydrogen bonds and hydrophobic contacts, thereby contributing to its potent α-glucosidase inhibitory activity.
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in cell cultures (in vitro) and computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.